Clinigen Group Plc (LON:CLIN) Ratings Summary as of May 17, 2018

May 17, 2018 - By Brian Ramirez

Clinigen Group Plc (LON:CLIN) Corporate Logo

Clinigen Group Plc (LON:CLIN) Ratings Coverage

In total 4 analysts cover Clinigen Group (LON:CLIN). “Buy” rating has 4, “Sell” are 0, while 0 are “Hold”. (LON:CLIN) has 100% bullish analysts. 12 are the (LON:CLIN)’s ratings reports on May 17, 2018 according to StockzIntelligence Inc. On Wednesday, April 4 the company was maintained by Peel Hunt. On Tuesday, February 27 the firm has “Buy” rating by Peel Hunt given. On Thursday, March 1 Peel Hunt maintained Clinigen Group Plc (LON:CLIN) with “Buy” rating. On Wednesday, November 29 the rating was reinitiated by N+1 Singer with “Buy”. On Thursday, February 1 Peel Hunt maintained Clinigen Group Plc (LON:CLIN) with “Buy” rating. On Monday, March 19 the firm has “Buy” rating given by Peel Hunt. On Tuesday, February 27 the firm has “Add” rating by Numis Securities given. On Tuesday, March 27 the firm has “Buy” rating given by Berenberg. In Wednesday, January 17 report Numis Securities maintained it with “Add” rating and GBX 1208 target. The stock rating was upgraded by Berenberg to “Buy” on Thursday, January 18. Listed here are Clinigen Group Plc (LON:CLIN) PTs and latest ratings.

04/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 Maintain
27/03/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1220.00 New Target: GBX 1160.00 Reiteration
19/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
27/02/2018 Broker: Numis Securities Rating: Add Old Target: GBX 1208.00 New Target: GBX 1208.00 Maintain
27/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
18/01/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1220.00 Upgrade
17/01/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 1225.00 New Target: GBX 1225.00 Maintain
17/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain

CLIN is hitting GBX 864 during the last trading session, after decreased 0.17%.Clinigen Group Plc has volume of 68,219 shares. Since May 17, 2017 CLIN has 0.00% and is . CLIN underperformed by 11.55% the S&P500.

Clinigen Group plc operates as a specialty pharmaceutical and services firm in the United Kingdom, Europe, the United States, and internationally.The firm is worth 1.06 billion GBP. The Company’s Clinigen Clinical Trial Services business supplies and manages commercial medical products, including comparator drugs, adjuvant drugs, and rescue therapies for patients in clinical trials, as well as provides value added services.77.14 is the P/E ratio. The companyÂ’s Idis Managed Access business is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.